In the twelfth installment of PhenoTips Speaker Series, Chief of the Division of Medical Genetics at the University of Pittsburgh School of Medicine, Dr. Jerry Vockely, and President and CEO of Rady Children’s Institute for Genomic Medicine, Dr. Stephen Kingsmore, prepare clinicians and researchers for the future of pediatric genetics.
As new technologies emerge and genetic testing becomes more accessible, pediatrics is expected to change dramatically, leaving many clinicians, clinics, researchers, and hospitals scrambling to keep up. To prepare clinicians and researchers for the impending future of pediatrics, PhenoTips invited Dr. Stephen Kingsmore and Dr. Jerry Vockely to discuss the upcoming challenges and potential solutions.
Dr. Stephen Kingsmore, the inaugural President & CEO of the Rady Children’s Institute for Genomic Medicine, previously held roles as Director of the Center for Pediatric Genomic Medicine at Children’s Mercy Hospital, President & CEO of the National Center for Genome Resources, and Chief Operating Officer of Molecular Staging Inc. Dr. Kingsmore’s rapid genome diagnosis was ranked as one of the top 10 medical breakthroughs of 2012 by TIME magazine, and his 26-hour genetic sequencing garnered him the Guiness World Record for the fastest genetic sequencing in the world.
Dr. Jerry Vockley is a medical geneticist certified in clinical, biochemical, and molecular genetics by the American Board of Medical Genetics and Genomics. He is chief of the Division of Medical Genetics, director of the Center for Rare Disease Therapy, and is the Cleveland Family Endowed Professor of pediatric research at the University of Pittsburgh School of Medicine. Dr. Vockley has published over 280 articles on multiple clinical and research topics. He is a member of the Board of the American College of Genetics and Genomics and is an active member of the Society for Inherited Metabolic Disorders, the American Society of Human Genetics, the Society for the Study of Inherited Metabolic Diseases, and the American Society of Clinical Investigation.
In this panel discussion moderated by DNA Today’s Kira Dineen, CGC, experts in pediatric genetics address: